|
|
Latest Story |
Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies |
GlobeNewswire |
Full Story → |
Headline News |
Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results |
5:45p ET March 25 '24 GlobeNewswire |
Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference |
12:31p ET March 22 '24 GlobeNewswire |
Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for "Neldaleucel" as Nonproprietary Name for MT-601 |
7:30a ET January 22 '24 GlobeNewswire |
More News → |
|
April 18 '24. Markets Closed. | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Previous data from yesterday, April 17 '24. |